Sweet elements of Siraitia grosvenori inhibit oxidative modification of low-density lipoprotein.

This study examined the ability of sweet elements extracted from Siraitia grosvenori (SG) to inhibit the oxidation of LDL. We monitored the formation of conjugated diene during copper-mediated LDL oxidation in the presence or absence of sweet elements of whole extract of SG (SG extract) or cucurbitane glycosides (CGs) purified from SG extract as sweet elements. CGs consist of Mogroside IV (Mog.IV), Mogroside V (Mog.V), 11-Oxo-mogroside V (11-Oxo-mog.V), and Siamenoside I (Sia.I). In addition, the effect of these elements on human umbilical vein endothelial cell (HUVEC)- mediated LDL oxidation was tested by measuring production of lipid peroxides. SG extract inhibited copper-mediated LDL oxidation in a dose-dependent fashion, but neither glucose nor erythritol suppressed the oxidation. Among CGs, 11-Oxo-mog.V significantly inhibited LDL oxidation, and prolongation of the lag time during LDL oxidation by 11-Oxo-mog.V was dose-dependent. The lag time (119.7 +/- 8.9 min) in the presence of 200 microM 11-Oxo-mog.V was significantly longer than that (76.8 +/- 5.5 min) of control (p < 0.01). In addition, SG extract and 11-Oxo-mog.V inhibited HUVEC-mediated LDL oxidation in a dose-dependent manner. These results demonstrate that SG extract can inhibit LDL oxidation and that 11-Oxo-mog.V, a sweet element of SG extract, provides the anti-oxidative property of SG which might reduce the atherogenic potential of LDL.

[1]  H. Esterbauer,et al.  Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein , 2009 .

[2]  P. Holvoet,et al.  Oxidized LDL and HDL: antagonists in atherothrombosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  P. Reaven,et al.  Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors , 2000, Current opinion in lipidology.

[4]  M. Kurabayashi,et al.  Circulating Oxidized Low Density Lipoprotein Levels: A Biochemical Risk Marker for Coronary Heart Disease , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[5]  A. Yonemura,et al.  Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein. , 1999, Biochemical pharmacology.

[6]  A. Ceriello,et al.  Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. , 1999, Metabolism: clinical and experimental.

[7]  D. Dunstan,et al.  Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. , 1999, Metabolism: clinical and experimental.

[8]  S. Grundy,et al.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.

[9]  D. Lichtenberg,et al.  Copper‐induced LDL peroxidation: interrelated dependencies of the kinetics on the concentrations of copper, hydroperoxides and tocopherol , 1999, FEBS letters.

[10]  C. Bisgaier,et al.  Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. , 1998, Atherosclerosis.

[11]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[12]  Tonutti,et al.  Antioxidant defences are reduced during the oral glucose tolerance test in normal and non‐insulin‐dependent diabetic subjects , 1998, European journal of clinical investigation.

[13]  R. Coleman,et al.  Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[15]  A. Yonemura,et al.  Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. , 1997, The American journal of clinical nutrition.

[16]  T. Ishikawa,et al.  Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[17]  D. Steinberg,et al.  Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.

[18]  L. Niskanen,et al.  Increased Resting and Exercise-Induced Oxidative Stress in Young IDDM Men , 1996, Diabetes Care.

[19]  D. Herold,et al.  Effects of Vitamin E on Susceptibility of Low-Density Lipoprotein and Low-Density Lipoprotein Subfractions to Oxidation and on Protein Glycation in NIDDM , 1995, Diabetes Care.

[20]  P. Edwards,et al.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.

[21]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[22]  G. Bellomo,et al.  Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM , 1995, Diabetes.

[23]  A. Chait,et al.  Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. , 1994, The Journal of clinical investigation.

[24]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[25]  E. Parks,et al.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.

[26]  S. Renaud,et al.  Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.

[27]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[28]  T. Lyons.  Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes? , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[29]  S. Wolff,et al.  Autoxidative Glycosylation and Possible Involvement of Peroxides and Free Radicals in LDL Modification by Glucose , 1990, Diabetes.

[30]  R. Kasai,et al.  Minor-cucurbitane-glycosides from fruits of Siraitia grosvenori (Cucurbitaceae) , 1990 .

[31]  R. Nie,et al.  Sweet Cucurbitane Glycosides from Fruits of Siraitia siamensis (chi-zi luo-han-guo), a Chinese Folk Medicine , 1989 .

[32]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[33]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[34]  M. S. Blois,et al.  Antioxidant Determinations by the Use of a Stable Free Radical , 1958, Nature.

[35]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[36]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[37]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[38]  W. Bors,et al.  Flavonoids as antioxidants: determination of radical-scavenging efficiencies. , 1990, Methods in enzymology.

[39]  H. Esterbauer,et al.  Vitamin E and other Lipophilic Antioxidants Protect LDL against Oxidation , 1989 .

[40]  J. Hokanson,et al.  [8] Single vertical spin density gradient ultracentrifugation , 1986 .